Hanu A R, Barberiz J, Bonneville D, Byun S H, Chen L, Ciambella C, Dao E, Deshpande V, Garnett R, Hunter S D, Jhirad A, Johnston E M, Kordic M, Kurnell M, Lopera L, McFadden M, Melnichuk A, Nguyen J, Otto A, Scott R, Wagner D L, Wiendels M
a NASA Goddard Space Flight Center, Greenbelt, Maryland 20771.
Department of bElectrical and Computer Engineering, McMaster University, Hamilton, Ontario L8S 4K1, Canada.
Radiat Res. 2017 Jan;187(1):42-49. doi: 10.1667/RR14491.1. Epub 2016 Dec 21.
During space missions, astronauts are exposed to a stream of energetic and highly ionizing radiation particles that can suppress immune system function, increase cancer risks and even induce acute radiation syndrome if the exposure is large enough. As human exploration goals shift from missions in low-Earth orbit (LEO) to long-duration interplanetary missions, radiation protection remains one of the key technological issues that must be resolved. In this work, we introduce the NEUtron DOSimetry & Exploration (NEUDOSE) CubeSat mission, which will provide new measurements of dose and space radiation quality factors to improve the accuracy of cancer risk projections for current and future space missions. The primary objective of the NEUDOSE CubeSat is to map the in situ lineal energy spectra produced by charged particles and neutrons in LEO where most of the preparatory activities for future interplanetary missions are currently taking place. To perform these measurements, the NEUDOSE CubeSat is equipped with the Charged & Neutral Particle Tissue Equivalent Proportional Counter (CNP-TEPC), an advanced radiation monitoring instrument that uses active coincidence techniques to separate the interactions of charged particles and neutrons in real time. The NEUDOSE CubeSat, currently under development at McMaster University, provides a modern approach to test the CNP-TEPC instrument directly in the unique environment of outer space while simultaneously collecting new georeferenced lineal energy spectra of the radiation environment in LEO.
在太空任务期间,宇航员会暴露在一股高能且高度电离的辐射粒子流中,这种粒子流会抑制免疫系统功能、增加患癌风险,甚至在暴露剂量足够大时引发急性辐射综合征。随着人类探索目标从近地轨道(LEO)任务转向长期的星际任务,辐射防护仍然是必须解决的关键技术问题之一。在这项工作中,我们介绍了中子剂量测定与探索(NEUDOSE)立方星任务,该任务将提供剂量和空间辐射品质因数的新测量数据,以提高对当前和未来太空任务癌症风险预测的准确性。NEUDOSE立方星的主要目标是绘制低地球轨道中带电粒子和中子产生的原位线能量谱,目前大多数未来星际任务的筹备活动都在该轨道进行。为了进行这些测量,NEUDOSE立方星配备了带电与中性粒子组织等效正比计数器(CNP - TEPC),这是一种先进的辐射监测仪器,它使用主动符合技术实时区分带电粒子和中子的相互作用。目前由麦克马斯特大学开发的NEUDOSE立方星提供了一种现代方法,可直接在独特的外层空间环境中测试CNP - TEPC仪器,同时收集低地球轨道辐射环境的新地理参考线能量谱。